* Correspondence: Omid Akbari, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Yes, the human clinical trial evidence is lacking, but there is a silver lining emerging from years of self-experimentation
UCB announces European Commission approval of Rystiggo (rozanolixizumab) for the treatment of adults with generalized myasthenia gravis in Europe [press release]
using it as an IV infusion or flush solution could result in excessive benzyl alcohol intake
Vitamin B12 deficiency can be uncovered with a simple blood test, and is highly treatable
However, highdensity lipoproteins cholesterol levels both increased in control and intervention groups following the treatment